©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 114953
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.114953
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.114953
Figure 1 The Consolidated Standards of Reporting Trials flow diagram of the study.
MLF: Medium-chain triglyceride-containing lactose-free formula; SLF: Standard lactose-free formula.
Figure 2 Stool frequency and consistency in pediatric patients with acute diarrhea receiving either medium-chain triglyceride-containing lactose-free formula or standard lactose-free formula during the 7-day intervention period.
A: Daily stool frequency (median values) in medium-chain triglyceride-containing lactose-free formula group (solid line) vs standard lactose-free formula group (dashed line); B: Daily assessment of stool consistency using the modified Bristol Stool Form Scale for Children, with medium-chain triglyceride-containing lactose-free formula group (black bars) and standard lactose-free formula group (gray bars). Modified Bristol Stool Form Scale for Children score of 3 represents normal stool consistency. MLF: Medium-chain triglyceride-containing lactose-free formula; SLF: Standard lactose-free formula; mBSFS-C: Modified Bristol Stool Form Scale for Children.
- Citation: Phavichitr N, Tantibhaedhyangkul R, Dumrisilp T, Prachuapthunyachart S, Chanpreecha W, Ratanamongkol P, Chongsrisawat V. Clinical outcomes of two lactose-free formulas in the management of acute childhood diarrhea. World J Clin Pediatr 2026; 15(1): 114953
- URL: https://www.wjgnet.com/2219-2808/full/v15/i1/114953.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v15.i1.114953
